# LISDEXAMFETAMINE DIMESYLATE
> **ANDA202836** · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 2024-07-26
## Drug
- **FDA Application Number:** ANDA202836
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LISDEXAMFETAMINE DIMESYLATE
- **Generic name:** LISDEXAMFETAMINE DIMESYLATE
- **Active ingredients:** LISDEXAMFETAMINE DIMESYLATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SANDOZ
- **Manufacturer:** Sandoz Inc
- **First approval:** 2024-07-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202836)
---
*AI Analytics · CC0 1.0*